OrganoClick AB (publ) (STO:ORGC)

OrganoClick AB Statistics

Total Valuation

OrganoClick AB has a market cap or net worth of SEK 177.65 million. The enterprise value is 257.99 million.

Market Cap	177.65M
Enterprise Value	257.99M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

OrganoClick AB has 110.00 million shares outstanding. The number of shares has increased by 3.92% in one year.

Current Share Class	110.00M
Shares Outstanding	110.00M
Shares Change (YoY)	+3.92%
Shares Change (QoQ)	+8.71%
Owned by Insiders (%)	49.51%
Owned by Institutions (%)	14.16%
Float	35.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.67
PB Ratio	8.71
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.09
EV / Sales	2.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-24.55

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 3.81.

Current Ratio	0.45
Quick Ratio	0.15
Debt / Equity	3.81
Debt / EBITDA	n/a
Debt / FCF	-7.40
Interest Coverage	-4.59

Financial Efficiency

Return on equity (ROE) is -130.50% and return on invested capital (ROIC) is -19.85%.

Return on Equity (ROE)	-130.50%
Return on Assets (ROA)	-14.80%
Return on Invested Capital (ROIC)	-19.85%
Return on Capital Employed (ROCE)	-70.05%
Weighted Average Cost of Capital (WACC)	8.81%
Revenue Per Employee	2.72M
Profits Per Employee	-932,590
Employee Count	39
Asset Turnover	0.81
Inventory Turnover	3.28

Taxes

Income Tax	-293,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.08% in the last 52 weeks. The beta is 0.98, so OrganoClick AB's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-34.08%
50-Day Moving Average	1.69
200-Day Moving Average	1.80
Relative Strength Index (RSI)	46.62
Average Volume (20 Days)	148,002

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OrganoClick AB had revenue of SEK 106.19 million and -36.37 million in losses. Loss per share was -0.36.

Revenue	106.19M
Gross Profit	14.86M
Operating Income	-31.04M
Pretax Income	-38.29M
Net Income	-36.37M
EBITDA	-12.33M
EBIT	-31.04M
Loss Per Share	-0.36

Balance Sheet

The company has 2.68 million in cash and 77.78 million in debt, with a net cash position of -75.11 million or -0.68 per share.

Cash & Cash Equivalents	2.68M
Total Debt	77.78M
Net Cash	-75.11M
Net Cash Per Share	-0.68
Equity (Book Value)	20.41M
Book Value Per Share	0.14
Working Capital	-49.71M

Cash Flow

In the last 12 months, operating cash flow was -8.29 million and capital expenditures -2.22 million, giving a free cash flow of -10.51 million.

Operating Cash Flow	-8.29M
Capital Expenditures	-2.22M
Free Cash Flow	-10.51M
FCF Per Share	-0.10

Margins

Gross margin is 13.99%, with operating and profit margins of -29.23% and -34.25%.

Gross Margin	13.99%
Operating Margin	-29.23%
Pretax Margin	-36.06%
Profit Margin	-34.25%
EBITDA Margin	-11.61%
EBIT Margin	-29.23%
FCF Margin	n/a

Dividends & Yields

OrganoClick AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.92%
Shareholder Yield	-3.92%
Earnings Yield	-20.47%
FCF Yield	-5.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OrganoClick AB has an Altman Z-Score of -2.58 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.58
Piotroski F-Score	1